Zika
On January 23, 2017, MSF file comments with the US Army in opposition to the grant of an exclusive license to patents on a new vaccine for the Zika Virus. A copy of the filing is on the MSF web page here.
View ArticleZika
The 2016-2017 Army Sanofi license on patents for a Zika vaccineNew, by Senator Bernie Sanders in the New York Times: Trump Should Avoid a Bad Zika Deal. March 10, 2017.KEI 2016-2017 comments on Army...
View ArticleMedImmune
Founded in 1988.January 29, 2004. Labs rush to cultivate bird flu vaccine Reverse genetics allows creation of weakened virus , Sabin Russell, Chronicle Medical Writerread more
View Article2017: GeneXion Oncology Prospective Grant of Exclusive Patent License for...
On May 31, 2017, we sent the following comment to the NIH regarding the proposed exclusive license on certain patents for cancer treatment to GeneXion Oncology.May 31, 2017Sury Vepa, Ph.D., J.D.,...
View Article2017: AbPro license of patents for liver cancer
This was our comment on the license. See below for the June 8, 2017 NIH response, rejecting our requests for changes to the license to address pricing or transparency. June 2, 2017David A. Lambertson,...
View Article2017: PathoVax license on Chimeric L1/L2 Protein . .. Human Papillomavirus...
On June 5, 2017, KEI provided comments to the NIH/NCI, on a prospective grant of an exclusive license to PathoVax, relating to HPV vaccines. On July 10, 2017, Kevin Chang responded (Copy of NIH...
View ArticleNovel HIV drug approvals
Names, Date of initial approval, FDA#, Medical Review. Retrovir, 3/19/1987, FDA#019655, Medical Review Videx, 10/9/1991, FDA#020154, 020155, 020156, Medical Review Zerit, 6/24/1994, FDA#020412, Medical...
View Article2017: NantBioScience - Commercial Application and Use of Fulvestrant in...
In 2016, the NIH signed a CRADA with NantBioScience, a company lead by Patrick Soon-Shiong, MD. to develop "Further Develop Recombinant NK Cells and Monoclonal Antibodies as Monotherapies and...
View Article2017: VeriLuce license of patents for pancreatic cancer treatment
On July 10, 2017, the NIH issued a notice on "Prospective Grant of Exclusive Patent License: Composition and Methods for Delivering Inhibitory Oligonucleotides for the Treatment of Pancreatic Cancer",...
View ArticleKEI statement regarding Gilead’s Acquisition of Kite Pharma
KEI statement regarding Gilead’s Acquisition of Kite Pharma.“Congress should require the NIH to enforce the Bayh-Dole obligation to make the Kite Pharma Chimeric Antigen Receptors Technologies (CAR T)...
View ArticleKymriah, the Novartis $475,000 CAR T treatment, received 50 percent Orphan...
Missing in the reporting on the Novartis price for Kymriah, its new $475,000 CAR T treatment, is that Novartis received an Orphan Drug designation in February 3, 2015, and sequently received a tax...
View ArticleKEI asks HHS to use Bayh-Dole rights in Zinbryta patent (drug for multiple...
Attached is a letter sent on September 14, 2017 to Andrew Bremberg, an Assistant to the President and the Director of the Domestic Policy Council at the White House, and Keagan Lenihan, a Senior...
View ArticleClik here to view.
Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria...
On Thursday, the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria unanimously endorsed a report that included very powerful recommendations on delinkage. This is a link to the...
View Article
